Human-derived extracellular matrix from Wharton's jelly: An untapped substrate to build up a standardized and homogeneous coating for vascular engineering
- PMID: 27769940
- DOI: 10.1016/j.actbio.2016.10.018
Human-derived extracellular matrix from Wharton's jelly: An untapped substrate to build up a standardized and homogeneous coating for vascular engineering
Abstract
One of the outstanding goals in tissue engineering is to develop a natural coating surface which is easy to manipulate, effective for cell adhesion and fully biocompatible. The ideal surface would be derived from human tissue, perfectly controllable, and pathogen-free, thereby satisfying all of the standards of the health authorities. This paper reports an innovative approach to coating surfaces using a natural extracellular matrix (ECM) extracted from the Wharton's jelly (WJ) of the umbilical cord (referred to as WJ-ECM). We have shown by atomic force microscopy (AFM), that the deposition of WJ-ECM on surfaces is homogenous with a controllable thickness, and that this easily-prepared coating is appropriate for both the adhesion and proliferation of human mesenchymal stem cells and mature endothelial cells. Furthermore, under physiological shear stress conditions, a larger number of cells remained adhered to WJ-ECM than to a conventional coating such as collagen - a result supported by the higher expression of both integrins α2 and β1 in cells cultured on WJ-ECM. Our data clearly show that Wharton's jelly is a highly promising coating for the design of human biocompatible surfaces in tissue engineering as well as in regenerative medicine.
Statement of significance: Discovery and design of biomaterial surface are a hot spot in the tissue engineering field. Natural matrix is preferred to mimic native cell microenvironment but its use is limited due to poor resource availability. Moreover, current studies often use single or several components of natural polymers, which is not the case in human body. This paper reports a natural extracellular matrix with full components derived from healthy human tissue: Wharton's jelly of umbilical cord. Reconstituting this matrix as a culture surface, our easily-prepared coating provides superior biocompatibility for stem and mature cells. Furthermore, we observed improved cell performance on this coating under both static and dynamic condition. This novel human derived ECM would be a promising choice for regenerative medicine.
Keywords: Biomimetic materials; Coating; ECM (extracellular matrix); Vascular tissue engineering; Wharton’s jelly.
Copyright © 2016 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
Similar articles
-
Differentiation of human umbilical cord Wharton's jelly-derived mesenchymal stem cells into endometrial cells.Stem Cell Res Ther. 2017 Nov 2;8(1):246. doi: 10.1186/s13287-017-0700-5. Stem Cell Res Ther. 2017. PMID: 29096715 Free PMC article.
-
Extracellular matrix derived from Wharton's Jelly-derived mesenchymal stem cells promotes angiogenesis via integrin αVβ3/c-Myc/P300/VEGF.Stem Cell Res Ther. 2022 Jul 18;13(1):327. doi: 10.1186/s13287-022-03009-5. Stem Cell Res Ther. 2022. PMID: 35851415 Free PMC article.
-
Osteogenic differentiation of Wharton's jelly-derived mesenchymal stem cells cultured on WJ-scaffold through conventional signalling mechanism.Artif Cells Nanomed Biotechnol. 2018;46(sup3):S1032-S1042. doi: 10.1080/21691401.2018.1528981. Epub 2018 Nov 19. Artif Cells Nanomed Biotechnol. 2018. PMID: 30449193
-
New emerging potentials for human Wharton's jelly mesenchymal stem cells: immunological features and hepatocyte-like differentiative capacity.Stem Cells Dev. 2010 Apr;19(4):423-38. doi: 10.1089/scd.2009.0299. Stem Cells Dev. 2010. PMID: 19958166 Review.
-
Umbilical cord revisited: from Wharton's jelly myofibroblasts to mesenchymal stem cells.Histol Histopathol. 2013 Oct;28(10):1235-44. doi: 10.14670/HH-28.1235. Epub 2013 Apr 18. Histol Histopathol. 2013. PMID: 23595555 Review.
Cited by
-
Systematic Review: Allogenic Use of Stromal Vascular Fraction (SVF) and Decellularized Extracellular Matrices (ECM) as Advanced Therapy Medicinal Products (ATMP) in Tissue Regeneration.Int J Mol Sci. 2020 Jul 15;21(14):4982. doi: 10.3390/ijms21144982. Int J Mol Sci. 2020. PMID: 32679697 Free PMC article.
-
Mesenchymal stem/stromal cell therapy in atopic dermatitis and chronic urticaria: immunological and clinical viewpoints.Stem Cell Res Ther. 2021 Oct 11;12(1):539. doi: 10.1186/s13287-021-02583-4. Stem Cell Res Ther. 2021. PMID: 34635172 Free PMC article. Review.
-
Umbilical Cord Matrix (Wharton Jelly) Mesenchymal Stem Cells in Next-generation Myocardial Repair and Regeneration: Mechanisms and Pre-clinical Evidence.Curr Cardiol Rev. 2025;21(5):76-103. doi: 10.2174/011573403X372908250117092252. Curr Cardiol Rev. 2025. PMID: 40012283 Review.
-
A silk fibroin/decellularized extract of Wharton's jelly hydrogel intended for cartilage tissue engineering.Prog Biomater. 2019 Mar;8(1):31-42. doi: 10.1007/s40204-019-0108-7. Epub 2019 Jan 31. Prog Biomater. 2019. PMID: 30706299 Free PMC article.
-
Cellularized small-caliber tissue-engineered vascular grafts: looking for the ultimate gold standard.NPJ Regen Med. 2021 Aug 12;6(1):46. doi: 10.1038/s41536-021-00155-x. NPJ Regen Med. 2021. PMID: 34385472 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous